Brian J. Lee to Join PayPal's Board of Directors
Former Goldman Sachs Chief Risk Officer brings extensive financial services, risk management, and regulatory expertise
Fastest customizable press release feed in the world.
Signed out · Sign up for real-time
Updates arrive automatically.
Former Goldman Sachs Chief Risk Officer brings extensive financial services, risk management, and regulatory expertise
Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced Scott Schaefer, Chief Financial Officer, will participate in a fireside chat at the BofA Securities Leveraged Finance Conference in Boca Raton, FL on Tuesday, December 1, 2026 at 7:30 a.m. ET (4:30 a.m. PT). The live webcast will be available at the following link: https://kvgo.com/2026-leveraged-finance-conference/herbalife-ltd-december A link to the webcast will also be available under the Investor Relations section of Herbalife's website at https://ir.herbalife.com/. A replay of the webcast will be available at the same website following the completion of the event and for six mo
Precision BioSciences, Inc. (NASDAQ:DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that, on November 16, 2026, the Compensation Committee of Precision’s Board of Directors approved the grant of inducement awards to new employees under the Precision BioSciences, Inc. 2021 Employment Inducement Incentive Award Plan ("Inducement Award Plan"). The inducement awards consist of an aggregate total of 39,146 restricted stock units ("RSUs"), granted among five employees in connection with their commencement of employment. Each award was granted under Nasdaq Listing Rul
HOTEL101-JOHOR BAHRU WITH APPROX. 606 ROOMS IS EXPECTED TO BE THE LARGEST HOTEL BY ROOM COUNT IN JOHOR BAHRU, MALAYSIA LOCATED AT A PRIME SITE AROUND 2 MINUTES DRIVE TO THE JOHOR BAHRU-SINGAPORE RTS TRAIN LINK Today, November 20, 2026: Hotel101 Global signs definitive binding agreements for the development of Hotel101-Johor Bahru, Malaysia Hotel101-Johor Bahru is set to have approx. 606 rooms on a 3,535 sqm site located on the corner of Jalan Tun Abdul Razak and the Johor Bahru Inner Ring Road, only around 2 minutes from the Bukit Chagar RTS Link Station, the key hub of the Johor Bahru-Singapore RTS Link Hotel101-Johor Bahru is expected to generate MYR275.73 million (US$66.78 mil
Just in Time for Holiday Shopping & ConsigningThe RealReal's third LA store offers personalized luxury consignment services, expert valuations and a constantly evolving assortment of one-of-one designer fashion, handbags, jewelry and watches
Frontier Minerals consortium to enter exclusive negotiations with Government of Kenya for prospecting licence for Mrima Hill, one of the world’s largest and highest grade rare earth projects,¹ and concurrently pursue potential non-dilutive funding including
The EXTEND study is the first clinical trial to evaluate xenotransplantation of a porcine thymokidney in a patient with end-stage renal disease (ESRD) EXTEND is the second clinical trial in United Therapeutics’ xeno-organ manufacturing program United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the first clinical xenotransplant in its EXTEND study of the UThymoKidney™ in patients with ESRD. The transplant operation was performed at NYU Langone Health. The ongoing EXTEND study will evaluate the safety and efficacy of the UThymoKidney in ESRD patients who are not eligible for conventional allogeneic kidney transplantation or who are on an Organ
Nouveau Monde Graphite Inc. ("NMG" or the "Company") ((NMG, The Company’s operations are not affected by the receipt of the Notification Letter. In addition, it has no immediate effect on the listing or trading of the Shares, which will continue to trade on the NYSE under the symbol "NMG", subject to the Company’s compliance with the NYSE’s other continued listing standards. The Shares are also listed on the Toronto Stock Exchange and the Notification Letter does not affect the Company’s compliance status with this listing. Under Section 802.01C of the NYSE Listed Company Manual, the Company has six months following receipt of the Notification Letter to regain compliance. The Company wil
Wabtec Corporation (NYSE:WAB) today announced the appointment of Rich J. Freeland to its Board of Directors, effective Monday, November 23rd. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261118040587/en/Wabtec Corporation Appoints Rich J. Freeland to the Board of DirectorsFreeland (69) brings more than 40 years of global industrial and operational leadership experience. He most recently served as President and Chief Operating Officer of Cummins Inc., where he helped drive the company’s growth, global expansion, operational excellence, and technology leadership across multiple business segments. During his tenure at Cummins, Freel
ERAS-0015 at 32 mg QD achieved 44% confirmed ORR in 2L+ KRAS G12X PDAC, despite heavy pretreatment (84% in the 3L+ setting) and a high proportion of G12R mutations (44% of patients) ERAS-0015 at 32 mg QD achieved 69% confirmed ORR in 2L+ KRAS G12D or G12V PDAC ERAS-0015 at 32 mg QD achieved 60% confirmed ORR in post-ICI/platinum (2L/3L) KRAS G12X NSCLC ERAS-0015 at 32 mg QD continued to be generally well tolerated, with mostly low-grade TRAEs and low rates of dose interruptions, reductions, and discontinuations Early combination data with gemcitabine plus nab-paclitaxel, pembrolizumab, and panitumumab support ERAS-0015’s combination backbone potential ERAS-4001 showed preliminary Phase
Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular" or the "Company")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to Ms. Tiffany Howard, the Company’s new Executive Vice President, Commercial – Retina. The awards were made as an inducement material to the recipient’s acceptance of employment with Ocular under Ocular’s 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement equity awards were granted effective as of November 16, 2026, and consist of a non-statutory stock option award to purchase up to
SS&C GlobeOp Forward Redemption Indicator: November notifications 2.31% SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) today announced the SS&C GlobeOp Forward Redemption Indicator for November 2026 measured 2.31%, up from 1.62% in October. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261120299377/en/SS&C GlobeOp Forward Redemption Indicator "SS&C GlobeOp’s Forward Redemption Indicator for November 2026 was 2.31%, compared with 2.43% a year ago and lower than the five-year average of 2.91% for November redemption notices," said Bill Stone, Chairman and Chief Executive Officer, SS&C Technologies. "Continued market volatility,
Adds One of the Nation's Leading Mechanical Platforms with More Than 119 Years of Operating History and Approximately 1,600 Employees, Including 1,200 Union Craft Workforce Enhances Technical Capabilities Through Industry-Leading Engineering, Prefabrication, Preconstruction and Self-Perform Execution Expertise Expands MasTec's Participation in Fast-Growing Mission-Critical Infrastructure Markets Including Aviation and Defense, Pharmaceutical, Healthcare, Technology and Advanced Manufacturing Creates Significant Opportunities to Expand Recurring Service and Maintenance Revenue Supporting Operational Data Centers and Other Diversified Markets Expected to Be Immediately Accretive
WeRide Inc. Announces Unaudited Financial Results for the Third Quarter of 2026
The Buckle, Inc. (NYSE:BKE) announced today that net income for the fiscal quarter ended October 31, 2026 was $48.0 million, or $0.95 per share ($0.94 per share on a diluted basis). Net sales for the 13-week fiscal quarter ended October 31, 2026 increased 2.6 percent to $329.2 million from net sales of $320.8 million for the prior year 13-week fiscal quarter ended November 1, 2025. Comparable store net sales for the 13-week fiscal quarter ended October 31, 2026 increased 0.6 percent from comparable store net sales for the prior year 13-week period ended November 1, 2025. Online sales decreased 1.4 percent to $52.2 million for the 13-week fiscal quarter ended October 31, 2026, compared to
Strong third quarter results reflect accelerating comparable sales, robust traffic growth and record membership; full-year comparable sales and EPS guidance raised Third Quarter Fiscal 2026 Highlights Comparable club sales increased by 13.5% year-over-year Comparable club sales, excluding gasoline sales, increased by 4.1% year-over-year Membership fee income increased by 9.5% year-over-year to $138.4 million Digitally enabled comparable sales growth was 38%, reflecting two-year stacked comp growth of 69% Earnings per diluted share and adjusted earnings per diluted share(a) of $1.73 The Company opened two new clubs and five new gas stations BJ’s Wholesale Club Holding
Sac-TMT is the first TROP2 ADC to improve OS compared to treatment of physician’s choice (TPC) in patients with advanced gastroesophageal adenocarcinoma who have received two or more prior lines of systemic therapy in a global Phase 3 study TroFuse-015 is the second positive Phase 3 readout from the global TroFuse clinical development program evaluating sac-TMT across multiple tumor types Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced the pivotal Phase 3 TroFuse-015 trial evaluating sacituzumab tirumotecan (sac-TMT), an investigational TROP2-directed antibody-drug conjugate (ADC) licensed from Kelun-Biotech, met its primary endpoint of overall su
Bullish (NYSE:BLSH), an institutionally focused global digital asset platform that provides market infrastructure and information services, today received System and Organization Controls (SOC) 1 Type 2 and SOC 2 Type 2 reports following the completion of examination engagements conducted by Deloitte1. The reports are for internal controls related to the digital assets exchange and associated custody services offered to customers onboarded with Bullish (GI) Ltd, Bullish Europe GmbH, Bullish US Operations LLC and Bullish HK Markets Limited for the year ending December 31, 2025. They are available
Granite (NYSE:GVA) announced today the appointment of Stan Bass to its Board of Directors, effective November 17, 2026. With more than 30 years of leadership experience in construction materials, operations, strategic growth, and business development, Mr. Bass brings significant industry expertise to support Granite's long-term strategy and continued expansion of its vertically integrated construction materials platform. Mr. Bass retired from Vulcan Materials Company in April 2026 after serving as Chief Strategy Officer. Before serving as Chief Strategy Officer, Mr. Bass held numerous executive leadership positions at Vulcan, including Division President, Senior Vice President, and Chie
BitFuFu Inc. ("BitFuFu" or the "Company") (NASDAQ:FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited financial results for the quarter ended September 30, 2026. Third Quarter 2026 Financial Highlights Total revenue was $37.7 million, down 79.1% from $180.7 million in the same period of 2025. This substantial decline reflects the combined effect of a 38.0% year-over-year drop in the average Bitcoin’s price during the period, softening demand for Cloud Mining Solutions, and the Company’s deliberate strategic optimization of deployed hashrate. Three Months Ended September 30, 2026 2025 Category